TechCrunch

SEPTEMBER 9, 2021

Neuroglee Therapeutics , a startup developing digital therapeutics for people with neurodegenerative diseases, has raised a $10 million Series A led by Openspace Ventures and EDBI. The funding will be used to launch virtual neurology clinics and to support Neuroglee’s move to Boston. Venture investing in elder tech.

digital therapeutics 93

digital therapeutics startup health support 93

HPA

MARCH 15, 2022

We’re excited to share that metaMe Health , a prescription digital therapeutics (PDT) company, today announced raising $2.2M We are thrilled to have the support of HPA as we prepare for the launch of Regulora,” said Tim Rudolphi, CEO of metaMe Health. “We in funding.

health 113

health digital therapeutics board support 113

HPA

MARCH 15, 2022

We’re excited to share that metaMe Health , a prescription digital therapeutics (PDT) company, today announced raising $2.2M We are thrilled to have the support of HPA as we prepare for the launch of Regulora,” said Tim Rudolphi, CEO of metaMe Health. “We in funding.

health 91

health digital therapeutics board support 91

TechCrunch

FEBRUARY 10, 2022

With the recent funding, Atommerce plans to enhance artificial intelligence and machine learning technology for its platform and invest in digital therapeutics specialized in mental illness. The Series B was led by Hashed, with participation from E&Investment, K2 Investment, and Samsung Next.

health 83

health digital therapeutics accelerator venture capital 83

TechCrunch

NOVEMBER 3, 2021

BrainCheck , a Houston- and Austin-based company developing cognitive healthcare software to aid physicians in detecting and managing this type of care, raised $10 million in Series B funding to expand its R&D and go-to-market capabilities as it works on new digital therapeutics for Alzheimer’s and related dementias.

digital therapeutics 116

digital therapeutics health ventures enablement 116

Angel Capital Association

MAY 18, 2020

MedRhythms, a Portland, Maine-based digital therapeutics company, is building direct stimulation, prescription therapeutics that use sensors, music, and software to improve loss of mobility caused by neurologic injuries and diseases. How does MedRhythms’ technology work?

digital therapeutics 40

digital therapeutics hospitality angel capital economic development 40

TechCrunch

MAY 12, 2023

is discussed,” said Amy Kruse, chief investment officer, Satori Neuro. Like several investors we surveyed, Kruse doesn’t solely invest in psychedelics, but they are very much on her radar. “Decriminalization is not the same as legalization at the Federal level. Will they take the lead?” Sa’ad Shah, managing partner, Noetic.

startup 99

startup digital therapeutics health development 99